Want to join the conversation?
Biopharmaceutical company $REGN and Intellia Therapeutics, Inc. announced a licensing and collaboration agreement to advance CRISPR/Cas gene-editing technology for in vivo therapeutic development. Intellia will receive a $75MM upfront payment and is eligible to receive significant milestone and royalty payments on potential $REGN products.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.